Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01651793 · ClinicalTrials.gov registry record · NA

Effect of Phytochemicals From Theobroma Cacao on Mental Energy

A NA study, sponsored by University of Georgia.

Completed
Registry status
NA
Development phase
24
Enrollment target

NCT01651793: Completed NA study, sponsored by University of Georgia.

NCT01651793 is a NA study that has completed, run by University of Georgia. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01651793, a NA study, has completed, sponsored by University of Georgia.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target

Study Summary

The purpose of this study is to determine which substances in cocoa produces changes in mental energy. This is a double blind study. The primary outcome measures are performance on tasks of sustained attention (serial subtract, continuous performance test and Bakan task) at pre and 90, 120 and 160 minutes post intervention, energy and fatigue symptoms (profile of mood state), and ratings of motivation to perform cognitive tasks. The assigned interventions are the following:

Primary Outcome

Participants subtract the number 7 from a three digit number and quickly and accurately as possible for 60 seconds. The total number of accurate responses is scored. The higher the score the better performance. The range of scores is from a minimum score of 0 to a theoretical maximum score of 120.

Interventions

  • OTHER Placebo
  • OTHER Caffeine
  • OTHER Cocoa
  • OTHER Caffeinated cocoa

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2012-07
Est. Completion 2014-06
Phase NA
University of Georgia

59 total trials

What the finished NCT01651793 record still lists

NCT01651793 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.

NCT01651793 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01651793 about?

NCT01651793 is a clinical study titled "Effect of Phytochemicals From Theobroma Cacao on Mental Energy". The purpose of this study is to determine which substances in cocoa produces changes in mental energy. This is a double blind study. The primary outcome measures are performance on tasks of sustained attention (serial subtract, continuous performance test and Bakan task) at pre and 90, 120 and 160 m...

What is the current status of trial NCT01651793?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2012-07. Estimated completion is 2014-06.

What interventions are being tested in trial NCT01651793?

The interventions under investigation include: Placebo (OTHER), Caffeine (OTHER), Cocoa (OTHER), Caffeinated cocoa (OTHER).

Who is sponsoring clinical trial NCT01651793?

This trial is sponsored by University of Georgia, which has 59 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01651793's enrollment target sits among peer trials

24 1736th of 2000 higher than 246 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01651793, the US trial registry maintained by the National Library of Medicine. NCT01651793 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.